TP53 and Ehlers-Danlos syndrome, musculocontractural type: P53 inactivation is observed in almost all ATCs suggesting that p53 deficiency, in association with activating mutations of oncogenes such as RAS and BRAF, drive the high proliferative index and high aggressiveness of these tumors.